288 related articles for article (PubMed ID: 29527328)
1. Targeting IL-2: an unexpected effect in treating immunological diseases.
Ye C; Brand D; Zheng SG
Signal Transduct Target Ther; 2018; 3():2. PubMed ID: 29527328
[TBL] [Abstract][Full Text] [Related]
2. Low-dose IL-2 therapy in autoimmune diseases: An update review.
Zhang R; Zhao Y; Chen X; Zhuang Z; Li X; Shen E
Int Rev Immunol; 2024 May; 43(3):113-137. PubMed ID: 37882232
[TBL] [Abstract][Full Text] [Related]
3. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases.
Xu L; Song X; Su L; Zheng Y; Li R; Sun J
Int Immunopharmacol; 2019 Jul; 72():322-329. PubMed ID: 31005777
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
6. Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives.
Matsuoka KI
Int J Hematol; 2018 Feb; 107(2):130-137. PubMed ID: 29234980
[TBL] [Abstract][Full Text] [Related]
7. Expansion of Regulatory T Cells In Vitro and In Vivo by IL-33.
Matta BM; Turnquist HR
Methods Mol Biol; 2016; 1371():29-41. PubMed ID: 26530793
[TBL] [Abstract][Full Text] [Related]
8. The Therapeutic Strategies of Regulatory T Cells in Malignancies and Stem Cell Transplantations.
Zaini RG; Al-Rehaili AA
J Oncol; 2019; 2019():5981054. PubMed ID: 30693029
[TBL] [Abstract][Full Text] [Related]
9. Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.
Li M; Eckl J; Abicht JM; Mayr T; Reichart B; Schendel DJ; Pohla H
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057512
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
[TBL] [Abstract][Full Text] [Related]
11. Revisiting IL-2: Biology and therapeutic prospects.
Abbas AK; Trotta E; R Simeonov D; Marson A; Bluestone JA
Sci Immunol; 2018 Jul; 3(25):. PubMed ID: 29980618
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 and autoimmune disease occurrence and therapy.
Geng X; Zhang R; Yang G; Jiang W; Xu C
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1462-7. PubMed ID: 23111957
[TBL] [Abstract][Full Text] [Related]
13. IL-6: regulator of Treg/Th17 balance.
Kimura A; Kishimoto T
Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
[TBL] [Abstract][Full Text] [Related]
14. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
15. Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.
Toomer KH; Malek TR
Cold Spring Harb Perspect Biol; 2018 Mar; 10(3):. PubMed ID: 28620098
[TBL] [Abstract][Full Text] [Related]
16. Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.
Gharibi T; Majidi J; Kazemi T; Dehghanzadeh R; Motallebnezhad M; Babaloo Z
Immunobiology; 2016 Feb; 221(2):357-67. PubMed ID: 26466984
[TBL] [Abstract][Full Text] [Related]
17. Potential route of Th17/T
Karri SK; Sheela A
Br J Biomed Sci; 2017 Jan; 74(1):8-15. PubMed ID: 28074676
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Blimp-1 function in effector regulatory T cells.
Cretney E; Leung PS; Trezise S; Newman DM; Rankin LC; Teh CE; Putoczki TL; Gray DH; Belz GT; Mielke LA; Dias S; Nutt SL
J Autoimmun; 2018 Jul; 91():73-82. PubMed ID: 29724515
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
Yu H; Paiva R; Flavell RA
Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
